The Department brings together a globally-recognised, multidisciplinary group comprising scientists, academic clinicians and research facilitators to develop innovative technologies and translate them into clinical practice. Our portfolio of platform technologies spans manufacture of biomaterials, biological applications of nanotechnology and tissue engineering, with applications to the clinic enabled by evidence based healthcare and clinical trials. Our aim is to drive uptake of innovative treatments and improve surgical practice to enhance patient benefit.